dpp-4 inhibitors vs. glp-1 agonist PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: DPP4 Were DPP-4 inhibitors the original
Description
Reply Please refrain from sharing personal health information in the comments
Semaglutide could ultimately be a valuable pharmacological alternative or add-on to these medications, however, more studies are needed to determine the efficacy of this drug, as well as its safety in people with average and below average BMI for whom weight loss could cause medical problems
At low doses, they take people back to a more normal food consumption pattern

Therefore, patients with unpredictable schedules may struggle with consistent absorption when using a GLP-1 pill regimen

You typically start at a low dose of 0.8 mg and gradually increase your dosage over a period of 3090 days
doi: 10.2337/dc16-1580
